GLP-1 medicines for teens with obesity: the honest picture
GLP-1 shots like Wegovy and Saxenda are now approved for teens aged 12 and older with obesity, and the STEP TEENS trial is encouraging. But long-term data in still-growing bodies is limited, and family-based lifestyle care stays the foundation. Here is what is approved, what the trials show, and the honest limits.
Unlock the complete article
Register with just your mobile number and OTP. No password and no payment.
Use this same phone number in the Burnie mobile app. Your profile, liked articles and favourites will stay synced.